U.S. Markets close in 4 hrs 14 mins
  • S&P 500

    3,664.02
    +1.57 (+0.04%)
     
  • Dow 30

    29,818.33
    -5.59 (-0.02%)
     
  • Nasdaq

    12,331.93
    -23.17 (-0.19%)
     
  • Russell 2000

    1,833.25
    -2.79 (-0.15%)
     
  • Crude Oil

    45.49
    +0.94 (+2.11%)
     
  • Gold

    1,831.40
    +12.50 (+0.69%)
     
  • Silver

    24.07
    -0.02 (-0.08%)
     
  • EUR/USD

    1.2093
    +0.0015 (+0.1209%)
     
  • 10-Yr Bond

    0.9510
    +0.0170 (+1.82%)
     
  • Vix

    20.77
    0.00 (0.00%)
     
  • GBP/USD

    1.3346
    -0.0077 (-0.5765%)
     
  • USD/JPY

    104.5370
    +0.2210 (+0.2119%)
     
  • BTC-USD

    18,913.49
    -80.41 (-0.42%)
     
  • CMC Crypto 200

    370.85
    +5.94 (+1.63%)
     
  • FTSE 100

    6,459.54
    +74.81 (+1.17%)
     
  • Nikkei 225

    26,800.98
    +13.44 (+0.05%)
     

Xeris Pharmaceuticals (XERS) in Focus: Stock Moves 6.8% Higher

Zacks Equity Research
·2 min read

Xeris Pharmaceuticals, Inc. XERS was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company—as the stock is now down 47.9% in the past one-month time frame.

The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Xeris Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Xeris Pharmaceuticals, Inc. Price

Xeris Pharmaceuticals, Inc. Price
Xeris Pharmaceuticals, Inc. Price

Xeris Pharmaceuticals, Inc. price | Xeris Pharmaceuticals, Inc. Quote

A better-ranked stock in the Medical - Drugs industry is Amneal Pharmaceuticals, Inc. AMRX, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.

See 8 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
AMNEAL PHARMACEUTICALS, INC. (AMRX) : Free Stock Analysis Report
 
Xeris Pharmaceuticals, Inc. (XERS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research